National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 34854-34855 [2018-15619]
Download as PDF
<![CDATA[
34854
Federal Register / Vol. 83, No. 141 / Monday, July 23, 2018 / Notices
Contact Person: Samuel C. Edwards, Ph.D.,
Chief, BDCN IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 5210, MSC 7846,
Bethesda, MD 20892, (301) 435–1246,
edwardss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–
RM18–018: Somatic Cell Genome Editing
Dissemination and Coordinating Center
(U24).
Date: August 16, 2018.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Elena Smirnova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5187,
MSC 7840, Bethesda, MD 20892, 301–357–
9112, smirnove@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 16, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–15606 Filed 7–20–18; 8:45 am]
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 5625 Fishers Lane, Bethesda,
MD 20892.
Contact Person: George Kunos, M.D., Ph.D.
Scientific Director, National Institutes of
Health, National Institute on Alcohol Abuse
and Alcoholism, 5625 Fishers Lane, Room
2s–24a Rockville, MD 20852 301–443–2069
gkunos@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
amozie on DSK3GDR082PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NIAAA.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute on Alcohol Abuse and
Alcoholism, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, NIAAA.
Date: October 2, 2018.
Time: 8:00 a.m. to 6:00 p.m.
VerDate Sep<11>2014
17:59 Jul 20, 2018
Jkt 244001
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2018–15610 Filed 7–20–18; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart,
Lung, and Blood Institute Special
Emphasis Panel Opportunities for
Collaborative Research at the NIH
Clinical Center.
Date: August 9, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: William J Johnson,
Ph.D., Scientific Review Officer, Office
of Scientific Review/DERA, National
Heart, Lung, and Blood Institute, 6701
Rockledge Drive, Room 7178, Bethesda,
MD 20892–7924, (301–827–7938)
johnsonwj@nhlbi.nih.gov.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
[FR Doc. 2018–15620 Filed 7–20–18; 8:45 am]
National Institutes of Health
National Institutes of Health
National Institutes of Health
Dated: July 17, 2018
Michelle D. Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: July 17, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
NHLBI R13 Conference Review.
Date: August 2–3, 2018.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Stephanie J. Webb, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7196, Bethesda, MD 20892, 301–435–0291,
stephanie.webb@nih.gov.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
E:\FR\FM\23JYN1.SGM
23JYN1
Federal Register / Vol. 83, No. 141 / Monday, July 23, 2018 / Notices
Dated: July 17, 2018.
Michelle D. Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–15619 Filed 7–20–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
34855
• Number of training and technical
assistance activities per funded
community provided by the grantee to
support communities
• Reach of training and technical
assistance activities (numbers served)
provided by the grantee
• Percentage of subrecipient
communities that submit data to the
grantee data system
• Number of subrecipient
communities that improved on one or
more targeted National Outcome
Measures
• Number of grantees who integrate
Prescription Drug Monitoring Program
(PDMP) data into their program needs
assessment
• Number of naloxone toolkits
distributed
Changes to this package include the
following:
• Inclusion of intervention names in
the standard tool
• Inclusion of community outcomes
reporting
• Inclusion of questions on training
services requested and referrals/
receiving treatment services in the PDO/
FR–CARA supplemental section
Proposed Project: Division of State
Programs—Management Reporting
Tool (DSP–MRT) (OMB No. 0930–
0354)—Revision
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center for Substance Abuse
Prevention (CSAP) aims to monitor
several substance abuse prevention
programs through the DSP–MRT, which
reports data using the Strategic
Prevention Framework (SPF). Programs
monitored through the DSP–MRT
include: SPF-Partnerships for Success,
SPF- Prescription Drugs, Prescription
Drug Overdose, and First ResponderComprehensive Addiction and Recovery
Act. This request for data collection
includes a revision from a previously
approved OMB instrument.
Monitoring data using the SPF model
will allow SAMHSA’s project officers to
systematically collect data to monitor
their grant program. In addition to
assessing activities related to the SPF
steps, the performance monitoring
instruments covered in this statement
collect data to assess the following
grantee required specific performance
measures:
ANNUALIZED DATA COLLECTION BURDEN
Number of
respondents
Instrument
amozie on DSK3GDR082PROD with NOTICES1
Standard DSP Monitoring Tool ............................................
Section A: Rx .......................................................................
Section B: PDO/FR CARA ...................................................
Section C: PFS ....................................................................
FY2020 Total .......................................................................
Written comments and
recommendations concerning the
proposed information collection should
be sent by August 22, 2018 to the
SAMHSA Desk Officer at the Office of
Information and Regulatory Affairs,
Office of Management and Budget
(OMB). To ensure timely receipt of
comments, and to avoid potential delays
in OMB’s receipt and processing of mail
sent through the U.S. Postal Service,
commenters are encouraged to submit
their comments to OMB via email to:
OIRA_Submission@omb.eop.gov.
Although commenters are encouraged to
send their comments via email,
commenters may also fax their
comments to: 202–395–7285.
Commenters may also mail them to:
Office of Management and Budget,
Office of Information and Regulatory
VerDate Sep<11>2014
17:59 Jul 20, 2018
Jkt 244001
117
25
23
71
117
Responses
per
respondent
4
2
4
1
........................
Affairs, New Executive Office Building,
Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2018–15677 Filed 7–20–18; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[1651–0122]
Agency Information Collection
Activities: Screening Requirements for
Carriers
U.S. Customs and Border
Protection (CBP), Department of
Homeland Security.
ACTION: 60-Day Notice and request for
comments; extension of an existing
collection of information.
AGENCY:
PO 00000
Frm 00033
Fmt 4703
Total number
of responses
Sfmt 4703
468
63
100
71
702
Hours per
response
3
1
1
3
........................
Total burden
hours
1404
42
100
213
1,759
The Department of Homeland
Security, U.S. Customs and Border
Protection will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995 (PRA). The
information collection is published in
the Federal Register to obtain comments
from the public and affected agencies.
DATES: Comments are encouraged and
will be accepted no later than
September 21, 2018 to be assured of
consideration.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice must include
the OMB Control Number 1651–0122 in
the subject line and the agency name.
To avoid duplicate submissions, please
use only one of the following methods
to submit comments:
(1) Email. Submit comments to: CBP_
PRA@cbp.dhs.gov.
SUMMARY:
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 83, Number 141 (Monday, July 23, 2018)]
[Notices]
[Pages 34854-34855]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-15619]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel Opportunities for Collaborative Research at the
NIH Clinical Center.
Date: August 9, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: William J Johnson, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892-
7924, (301-827-7938) [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
[[Page 34855]]
Dated: July 17, 2018.
Michelle D. Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-15619 Filed 7-20-18; 8:45 am]
BILLING CODE 4140-01-P
